IRCT20180203038601N1已完成2 期
Metastatic bone pain palliation using 177Lu/153Sm-EDTMP cocktail: a clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •Cancerous patients with metastatic lesions in bone and with a positive bone scan coincident with pain location, maximally one month before treatment
- •Suitable CBC at least one week before treatment
- •Normal liver and kidney function
排除标准
- •Inappropriate function of liver or kidney
研究者
相似试验
已完成
1 期
Clinical trial of Lu-177- HEDMP for bone pain palliation of bone metastasis in breast cancerIRCT201109217611N1Shiraz University of Medical Sciences30
已完成
1 期
An early phase clinical trial evaluating the effectiveness of treatment of 177Lu-PSMA with idronoxil in men with castrate-resistant prostate cancer (LuPin Trial)ACTRN12618001073291St Vincent's Hospital Sydney56
招募中
1 期
Pain management in patients with metastatic bone cancer based on the theory of 'wrist-ankle acupuncture': study protocol for a randomized controlled trialmetastatic bone cancerITMCTR2100004466Affiliated Hospital of Chengdu University of TCM
Unknown
2 期
177Lu-PSMA-I＆T PSMA Radioligand Therapy in Metastatic Castration-Resistant Prostate CancerMetastatic Castration-resistant Prostate CancerNCT04188587Nanjing First Hospital, Nanjing Medical University30
已完成
1 期
Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate CancerProstate NeoplasmNCT03828838Radboud University Medical Center10